JAZZCommon stockNASDAQ
JAZZ Common stock
This is the ticker-level security page. The issuer is Jazz Pharmaceuticals.
Security details
Issuer financial context
These figures belong to the issuer company, not to this security itself.
Revenue TTM
$4.2B
Net income TTM
-$368.5M
Total assets
$11.4B
Total debt
$5.4B
Total equity
$4B
Profit margin
-8.9%
ROE
-9.3%
ROA
-3.2%
Latest issuer financial snapshot: 2024-12-31